Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_1
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (50.0%)
N/A2 (50.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_1

Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients

NCT04102852
completednot_applicable

The Effect of Single Probiotic on Metabolic Control in Type 2 Diabetes

NCT05066152
completednot_applicable

Probiotics and Examination-related Stress in Healthy Medical Students

NCT03427515
completedphase_1

Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers

NCT00934453

Clinical Trials (4)

Showing 4 of 4 trials
NCT04102852Phase 1

Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients

Completed
NCT05066152Not Applicable

The Effect of Single Probiotic on Metabolic Control in Type 2 Diabetes

Completed
NCT03427515Not Applicable

Probiotics and Examination-related Stress in Healthy Medical Students

Completed
NCT00934453Phase 1

Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4